Arkolith/Insider Trading/LGND/Form 4

Lamattina John L

DirectorLIGAND PHARMACEUTICALS INC (LGND) · full profile →Form 4 · filed Jun 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.2M
Net Open-Market Flow
-$1.2M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 10, 2026Sell(S)257$247.22$64K31K
Jun 10, 2026Sell(S)232$248.11$58K31K
Jun 10, 2026Sell(S)697$249.53$174K30K
Jun 10, 2026Sell(S)3K$251.62$857K27K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002001011-26-000102) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML